Search

Heart palpitations are the sensations or feelings that accompany an excessively rapid, skip-beat, or fluttering heartbeat. Heart palpitations can be brought on by a variety of factors, such as anxiety, tension, fear, caffeine, nicotine, some medications, dietpills, physical activity, and fever. Herbal remedies have long been utilized widely in the therapeutic management of palpitations because available synthetic medications have substantial negative effects. The purpose of this study is to assess the safety and effectiveness of the Unani medication Jawarish-e-Shahi in patients experiencing palpitations. The information provided here is an open-level, multicentric clinical study that was carried out at the "Regional Research Institute of Unani Medicine in Aligarh", Uttar Pradesh, from 2016 to 2019 on 74 cases of palpitation streated with Jawarish-e-Shahi. A p-value of<0.05 was proved to be significant in the statistical analysis of the presented data, which was conducted using one-way analysis of variance (ANOVA) and Dunnett's test. The study's findings, which were compared to baseline data from various follow-ups of palpitation cases treated with Jawarish-e-Shahi, demonstrated a notable improvement in a number of palpitation symptoms, including anxiety, perspiration, nausea, vomiting, and chest heaviness. A significant decline in diastolic pressure and pulse rate had also been observed. Reduction in number of pallor (pale appearance of patients) in baseline, 1st follow-up and post-treatment had been noted. Based on the investigation, the Unani medicine is safe and non-toxic. More research on a large size of population with palpitations is suggested for further study. [ABSTRACT FROM AUTHOR]

Present study evaluated the therapeutic efficacy and safety of two Unani compound drugs namely Majun-e-Suranjan and Habb-e-Azraqi in cases of gout on modern scientific parameters viz., clinical, biochemical and haematological. This work was conducted at Regional Research Institute of Unani Medicine (RRIUM), Aligarh, during 2014-2019. 71 people were chosen from the pool of patients visiting the outpatient department (OPD). Patients received the Unani medicines Majun-e-Suranjan in a dose of 5.0 g and Habb-e-Azraqi in a dose of 1 pill (250 mg) twice daily after meals for a period of 56-days. One-way analysis of variance (ANOVA) was used for the analysis of data, and the statistical significance of the findings was determined by Dennett's test. The study reveals that the two Unani medicines are safe, non-toxic, and significantly relieve the symptoms of gouty arthritis. It is suggested to conduct more research among a large population. [ABSTRACT FROM AUTHOR]

The current pandemic caused by Severe Acute Respiratory Syndrome Corona-Virus 2 (SARS-CoV-2) has become a global health menace with significant morbidity and mortality besides huge socioeconomic implications. Despite the approval of few vaccines for the prevention of the disease, the discovery of safe and effective countermeasures especially from natural sources is of paramount importance, as the number of cases continues escalating. Arq Ajīb has long been used for various diseases and its ingredients have been reported for antiviral, antimicrobial, antipyretic, anti-inflammatory, antioxidant activities. The present study investigates the inhibitory effect of phytocompound of Arq Ajīb on potential drug targets of SARS-CoV-2. The structures of phytocompounds present in Arq Ajīb were retrieved from PubChem database and some were illustrated using Marvin Sketch. SARS-CoV-2 S glycoprotein (PDB ID: 6LZG) and 3CLpro (PDB ID: 7BQY) were selected as the target protein. Dock Prep module in UCSF Chimera software was used for receptor structure processing. AutoDock Vina was used to calculate the binding affinities between the protein and ligands and to predict most promising compounds with best scores. Molecular docking results predicted that the phytocompounds of Arq Ajīb had good binding affinity and interaction with S glycoprotein and 3CLpro. Quercetin and Isorhoifolin from Mentha arvensis were identified as promising candidates with the potential to interact with 3CLpro and spike glycoprotein and inhibit the viral replication and its entry into the host. Arq Ajīb may prove valuable for developing novel therapeutic candidate for COVID-19; however, it has to be substantiated further with in-vitro and in-vivo studies. [ABSTRACT FROM AUTHOR]

Hypertension is predominant condition throughout the world. In Unani (Greek Medicine) hypertension is associated with the Damwi (Sanguine) Temperament. Oxidative stress is implicated in pathogenesis of the hypertension. Hence, GSTT1, GSTM1 and eNOS gene polymorphisms and antioxidant activity were examined in Hypertensive patients’ and healthy controls with Damwi temperament. The eNOS genotyping was done by PCR and RFLP method whereas GST-M1 and GST-T1 genotyping were analyzed by multiplex PCR. In serum samples oxidants and antioxidants were measured by ELISA in 200 Sanguine subjects. The GT genotype of eNOS, GSTM1 and GSTT1 null genotype frequency was found to be high in hypertensive patients (21%,36%,28%) compared to control samples GT (13%, 10%, 04%), respectively. GR, GST and MDA are significantly in correlation with each other. The results of the study indicate reduced antioxidant activity and increased oxidative stress in hypertensive patients with significantly high GSTM1, GSTT1 null genotypes and serum glutathione transferase. Therefore, balancing of antioxidants could be useful in the management of essential hypertension. [ABSTRACT FROM AUTHOR]

The use of detergent-action drugs in traditional Unani therapeutic intervention has been a long-standing Unani medicinal practice. The key aim of the article is to provide thorough information on the novel, unexplored idea of Unani Jali (detergent/cleansers) drugs for the treatment of skin ailments, as well as to identify medicinal plants that have detergent action and correlate these findings with scientific studies that may support evidence for the drug's detergent effect. The ethnobotanical classical literature of Unani medicine was investigated in order to have a comprehensive insight of Unani detergents/cleansers. Scientific studies were carried from databases including PubMed, Scopus, Science Direct, and google Scholar, among others. More than fifty exclusive plant, mineral, and animal-based detergents are found specifically for skin disorders in Unani therapy. These drugs basically evacuate impurities from the body's excretory system and and have been found to have keratolytic and debris-peeling effects, as well as the ability to maintain skin tone consistency. Unani Jali drugs have also been found to have anti-inflammatory, antibacterial, analgesic, and tonic properties, suggesting its usefulness holistically. Based on phyto constituents, prospective therapeutic response, and scientific data, this review proposes that Unani Jali drugs could be a safe and promising therapeutic option for dermatological illnesses such as vitiligo, acne, dermatitis, psoriasis, and skin sensitivity. [ABSTRACT FROM AUTHOR]

This article aims to discuss the impact of air quality on human health, measures to achieve the goal of good indoor air quality and proposed benefits of interventions of Unani Medicine with an evidence-based approach. The significance of air quality on the health of the community cannot be denied. Recent evidences from WHO illustrated data on severe air pollutants and their impacts on human health ranges from minor upper respiratory irritation to chronic respiratory ailments including lung carcinoma and heart disease associated with premature mortality and reduced life expectancy. In Unani Medicine, air has been included in the list of factors, which are six in number and play the central role in prevention of diseases and maintenance of health. Air is considered as the medium of most of the extrinsic factors such as chemical and biological pollutants affecting health and their exposure results in short and long-term health issues. The literature of Unani Medicine proposes many simple and effective measures, which help to improve indoor and outdoor air quality. The goal of outdoor clean air is achieved through implementation of measures to tackle the source of pollution, while indoor clean air is attained through various means e.g., fumigation with herbal drugs. Hence, an extensive literature survey on Unani reserve was conducted to collect information about the concept of air discussed under the heading of six essential factors and its implication in prevention of diseases and maintenance of health. Further, research databases such as Pub Med, Google Scholar, and Science-Direct were broadly searched for evidence on the efficacy of herbals mentioned in Unani literature for the indoor air purification and subsequent air quality improvement. Recent studies showed good air quality leads to decrease in mortality, particularly of respiratory and cardiovascular deaths whereas poor air quality results in a variety of diseases. Unani scholars prescribed several regimens such as Bukhoor (Fumigation), Sa'oot (Nasal instillation) and use of Abeer (Perfumes) and Nadd (Incense) for the improvement of air quality. Likewise various herbal fumigants and sprays containing drugs like mī'a sā'ila (Liquidambar orientalis Mill.), mastagi (Pistacia lentiscus L.), mushk (Moschus moschiferus L.), loban (Styrax benzoides W. G. Craib), ābnoos (Diospyros ebenum J. Koenig ex Retz), zā'fran (Crocus sativus L.) and sirka (vinegar) etc. has been well explained and used exclusively for air purification and improvement of AQI. Therefore, in the present scenario of altered air quality, we forward certain measures described in Unani system of medicine for health promotion and protection. Scientific evidence on several drugs reveal the presence of a number of pharmacologically active substances, which may provide a new approach into the purification of air. [ABSTRACT FROM AUTHOR]

Liver plays a major role in metabolism and excretion of xenobiotics. Liver dysfunction is a major health problem that challenges health care professionals, pharmaceutical industry and drug regulatory agencies. The most common symptoms are fatigue and discomfort in abdomen while in patients who are obese with BMI > 25, about one third have metabolic syndromes. The present clinical research was conducted in Regional Research Institute of Unani Medicine, Aligarh. The patients under trial were selected from GOPD of institute for obesity and it was observed that out of total registered patients' approx 28% have elevated liver enzymes from its normal range without any sign and symptom of hepatitis etc. Total 23 patients were selected from the study whose liver enzymes (SGOT, SGPT and ALP) were high at the baseline. Unani pharmacopoeial drug Jawārish bisbāsā 7 g daily was prescribed with lukewarm water in the morning and evening empty stomach for 8 weeks. At the end of study the result were compared with base line. It was observed that Jawārish bisbāsā significantly reduced the liver enzymes, e.g. SGOT, SGPT, Alkaline Phosphatase in comparison to baseline values. It may be concluded that Jawārish bisbāsā showed hepatoprotective effect in this clinical study. [ABSTRACT FROM AUTHOR]

Tristeza disease is caused by citrus tristeza virus (CTV) expresses salient symptoms like stem pitting, yellowing of leaves, stunted growth of large, small lateral branches and twigs. The study was carried out to quantify the spatial and temporal distribution of CTV disease in major citrus growing areas of Sargodha district (Sargodha, Kot Momin, and Bhalwal). The samples from the declined orchards were collected based on symptomology and confirmed through ELISA. CTV was detected in 3 varieties viz., Kinnow (Citrus reticulate), Mosambi (Citrus sinensis) and Feutrell's early (Citrus reticulate cv feutrell's early). The maximum disease incidence was recorded in Mosambi (90%), followed by Feutral's early (74%) and Kinnow (57%). Mosambi was the most susceptible within the range of OD values (0.82-2.35) followed by Feutrell's early (0.45-0.64) and Kinnow (0.25-0.56). The disease severity was recorded only on Mosambi as it was more affected than Feutral's early and Kinnow. The rating scale to observe the severity of tristeza disease was based on percentage of pits in the 1 sq. inch piece of bark at bud union of infected tree. This rating scale has been developed for the first time to record the tristeza disease severity. The maximum disease severity was recorded in Kot Momin (62%) followed by Bhalwal (56%) and Sargodha (50%). The study concluded that CTV is one of the most promising factors playing role in the citrus decline. [ABSTRACT FROM AUTHOR]

Alzheimer's disease (AD) is one of the prominent causes for disability and lowered quality of life worldwide in elderly population. It has fostered immense burden to AD patients, families and society. Burgeoning progress in the field of pathogenesis over last two decades has persuaded the investigation of novel pharmacological therapeutics that focuses towards the pathophysiological events of AD. Miscellaneous clinical trials, development and testing of interventions aimed at various targets, such as anti‐tau and anti‐amyloid interventions, neurotransmitter modification, neuroprotection and anti‐neuroinflammation interventions, cognitive enhancement and interventions to palliate behavioural symptoms have been carried out. Despite massive efforts to find disease‐modifying therapies, there lingers a vital need for continuing the advancement in progress of the AD research. This review features the new developments of small molecule compounds that will be beneficial in evolution of new AD therapies. In particular, this review briefly describes summary of mechanistic causes chiefly associated with AD and focuses on medicinal approach via small molecule inhibitors that can manage cognitive impairment and dysfunction and may combat Alzheimer's development. [ABSTRACT FROM AUTHOR]

Background: Regardless of amazing advancements in contemporary science & technology, it is not possible to provide everyone access to high-quality healthcare. Traditional medicine, in particular Ayurveda and Unani medicine, is regarded as a major global provider of healthcare. This manuscript is aimed to provide the promulgation of Unani Medicine in contemporary healthcare system. Methods: A in-depth literature analysis was successfully carried out from year 2006 to 2021 to collate the information on the advancement, growth and development of the Unani System of Medicine (USM). The search strategy was performed with recent surveys, articles and the numerous initiatives undertaken by the Ministry of AYUSH, Centre council in research in unani medicine (CCRUM) & other institutions on Unani education and research. Additionally, the updated market analysis (2020-2022) comprises import, export and trade data on Unani medicines is also described. From what we know, this review is the first of a kind to describe the domestic and global perspective of Unani medicine with and its global development. Results: The multi-disciplinary, multi-centric research initiatives of the Ministry of AYUSH have resulted in an increase in medical facilities and education in the Unani System of Medicine. With 1748 Unani dispensaries and 3947 beds in Unani hospitals, the number of these facilities has grown at a 2.4% annual pace between 2011 and 2021. Conclusion: There is tremendous growth in Unani as well as in herbal industry. Unani Medicines have shown their potential and need for better drugs and remedies against various diseases. The knowledge on import and export and the information on research and education enable to work more in this domain. These initiatives favour the World Health Organisation advocating Unani medicine as a better alternative system against various diseases. [ABSTRACT FROM AUTHOR]

Objectives: The study aimed to establish the effectiveness of Unani add-on regimen by comparing theduration required for change in disease status from COVID-19 positive asymptomatic / mildto moderate symptomatic patients to asymptomatic negative. Methods: This single-centric, randomized, twin arm, controlled, clinical trial was carried out on a totalnumber of 62 RT-PCR confirmed COVID-19 patients. The Intervention group (IG) receivedUnani Regimen (Khameera Marwareed and Unani Joshanda) in addition to the conventional management, while the Control group (CG) received only conventional management. Results: It was observed that 16 (51.6%) patients in Intervention Group and 3 (9.4%) patients incontrol group became negative for COVID-19 at day 7 and remaining 13 out of 15 (93.5%) patients in Intervention Group and 20 out of 28 (74.1%) patients in control group becamenegative for COVID-19 at day 14. This effect of the Unani Regimen in comparison to thecontrol group was statistically significant (p =0.003). Conclusions: It can be concluded that the change of COVID-19 positive asymptomatic / mild to moderate symptomatic patients to RT-PCR negative was much earlier in the add-on Unani regimen group as compared to control group. [ABSTRACT FROM AUTHOR]

SARS-CoV-2 has been responsible for over 500 million cumulative cases all over the world since December 2019 and has marked the third introduction of a highly pathogenic virus after SARS-CoV and MERS-CoV. This virus is in a winning situation because scientists are still racing to explore effective therapeutics, vaccines, and event treatment regimens. In view of progress in current disease management, until now none of the preventive/treatment measures can be considered entirely effective to treat SARS-CoV-2 infection. Therefore, it is required to look up substitute ways for the management of this disease. In this context, herbal medicines could be a good choice. This article emphasizes the antiviral potential of some herbal constituents which further can be a drug of choice in SARS-CoV-2 treatment. This article may be a ready reference for discovering natural lead compounds and targets in SARS-CoV-2 associated works. [ABSTRACT FROM AUTHOR]

Objectives Limited treatment options are available for advanced stages of chronic myeloid leukaemia (CML). Moreover, patients' relapse after a short remission period, which prompts them to identify a potent drug with the least toxicity. An Unani herbal formulation, Itrifal-e-Aftimoon (IEA) is used for certain neurological disorders, however, its antitumor potential has not been reported yet in any malignancy, including CML. Methods The aqueous extract of IEA was characterized by HPLC/LC-MS and used alone or in combination with standard drug, imatinib in CML cell lines (K562, KU812) in vitro to assess its effect on cancer-associated parameters such as cytotoxicity, cell cycle, apoptosis, oxidative stress, inflammation, angiogenesis, and certain signalling pathways. Results LC–MS characterization of IEA showed the presence of antitumor compounds including catechin and caffeic acid. Treatment with IEA caused cytotoxicity and arrested cells in the sub-G0/G1 phase. Subsequent assays confirmed apoptosis-mediated cell death with mitochondrial membrane depolarization and alleviation of oxidative stress. IEA abrogates IL-6, VEGF, angiopoietin-2, and alters Th1/Th2 cytokines. IEA potentiated the effect of imatinib even at lower doses by affecting FAK/STAT/Akt/ERK pathways. Conclusion IEA possesses antitumor potential against CML and increases the efficacy of imatinib when used in combination, suggesting utilization of IEA as an adjuvant therapy for better management of CML in the future. [ABSTRACT FROM AUTHOR]

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally. COVID-19 presents varied clinical features. The present study focuses on number of patients turning COVID-19 positive, change in Immune Status Questionnaire (ISQ) and WHO quality of life- Bref (WHO Qol – BREF) scales after taking intervention. This open labelled, double arm, controlled, interventional, clinical trial was conducted on high-risk individuals i.e., those residing with a COVID-19 positive member in the identified quarantine area. This twin armed study was conducted on asymptomatic individuals exposed to COVID -19. The test group were prescribed Unani poly-herbal decoction together with Unani formulations Khamira Marwareed and Tiryaq e Arba whereas the control group was not on any intervention. The duration of intervention was 20 days; follow ups were planned on day 10 and day 20. Of the 81 participants enrolled, none of the patients turned COVID-19 positive. However, 13.58% (n=11) developed COVID like symptoms and 70 patients completed the study. The mean age of the participants was 41.42±16.9 years; however, majority of the participants were 18-28 years male with Damvi (Sanguine) temperament. The quality of life of the intervention group improved significantly however, the immune status in both the groups increased with P <0.001. The Unani prophylactic regimen provides a 62% (relative risk reduction) protection against COVID -19. This pilot study paves for a study on a larger population. No adverse effects were observed during the study. Absence of biochemical investigations were limitations to the study. [ABSTRACT FROM AUTHOR]

Tuberculosis continues to be a major public health problem globally, despite incredible advancements in healthcare system. In Unani system of medicine, Qurs Tabasheer Sarthani (QTS) and Arq Hara Bhara (AHB) have been traditionally used for tuberculosis like conditions. The study was aimed to investigate the effects of co-administration of QTS and AHB with category I first line antitubercular drugs (CAT-I) on the indices of liver and kidney function in rats. QTS and AHB were prepared individually and mixed to achieve final compound Unani pharmacopoeia formulation (UPF). The human equivalent doses for rats were calculated and administered with and without CAT-I. The effects of the formulations on serum indices of kidney and liver function, hematological markers and plasma CAT-I drug levels were estimated at 14th, 60th & 180th days of treatment. The administration of UPF, CAT-I and UPF + CAT-I altered the levels of aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and gamma glutamyltransferase (GGT) and haematological markers. These alterations were within permissible range and randomly distributed among groups during various time points. Administration of CAT-I alone resulted in moderate histopathological changes which were completely abrogated in CAT-I + UPF co-administered animals. The co-administration of UPF with CAT-I improved the plasma peak rifampicin (RIF) levels, without altering the liver and kidney functions. The co-administration of UPF with ATT improved liver and kidney functions and increased the plasma levels of RIF. These beneficial findings provide a scope to evaluate the pharmacokinetic studies in humans. [ABSTRACT FROM AUTHOR]

Emergence of antimicrobial resistance, with practically all newly developed and even more potent antibiotics like carbapenem and colistin, has become a matter of great public health concern. A number of common diseases of public health importance are becoming harder and sometimes impossible to treat due to increased resistance of pathogens. These alarming threats seek prime attention of scientific community to develop newer antibiotics with long-lasting efficacy, least side effects, and low economic burden. Unani classical texts have enormous citations on different infectious diseases. Many single drugs and compound formulations are in vogue since ages for the treatment of infectious diseases. Use of Afaviya (spices), Mufarrehat (exhilarants), Tiryaqi Advia (drugs with antidote properties) and Sirka (vinegar) is highly advocated in treating various infectious diseases. Though, enormous research activities have been undertaken worldwide to explore and develop newer antibiotics from natural resources, indicating massive magnitude of natural products in treating various infectious diseases, however, the higher plants, still largely seems to be unexplored. Moreover, elaborated and well controlled clinical studies are still lacking to authenticate their clinical significance. Hence, a rigorous, well-designed & well-structured research is highly paramount to ascertain the provision of newer, relatively safe and cost effective natural antibiotics. [ABSTRACT FROM AUTHOR]

Breast cancer has become a menacing form of cancer among women accounting for 11.6% of total deaths of 9.6 million due to all types of cancer every year all over the world. Early detection increases chances of survival and reduces the cost of treatment as well. Screening modalities such as mammography or thermography are used to detect cancer early; thus, several lives can be saved with timely treatment. But, there are interpretational failures on the part of the radiologists to read the mammograms or thermograms and also there are interobservational and intraobservational differences between them. So, the degree of variations among the different radiologists in the interpretation of results is very high resulting in false positives and false negatives. The double reading can reduce the human errors involved in the interpretation of mammograms. But, the limited number of medical professionals in developing or underdeveloped countries puts a limitation on this remedial way. So, a computer-aided system (CAD) is proposed to detect the benign cases from the abnormal cases that can result in automatic detection of breast cancer or can provide a double reading in the case of nonavailability of the trained medical professionals in developing economies. The generally accepted screening modality is mammography for the early detection of cancer. But thermography has been tried for early detection of breast cancer in recent times. The high metabolic activity of the cancer cells results in an early change in the temperature profile of the region. This shows asymmetry between normal and cancerous breast which can be detected using different techniques. Thus, this work is focussed on the use of thermography in the early detection of breast cancer. An experimental study is conducted to find the results of classification accuracy to compare the efficacy of thermography and mammography in classifying the normal from abnormal ones and further abnormal ones into benign and malignant cases. Thermography is found to have classification accuracy almost at par with mammography for classifying the cancerous breasts from healthy ones with classification accuracies of thermography and mammography being 96.57% and 98.11%, respectively. Thermography is found to have much better accuracy in identifying benign cases from the malignant ones with the classification accuracy of 92.70% as compared to 82.05% with mammography. This will result in the early detection of cancer. The advantage of being portable and inexpensive makes thermography an attractive modality to be used in economically backward rural areas where mammography is not practically possible. [ABSTRACT FROM AUTHOR]

COVID-19 was originated in Wuhan, China, in December 2019 and has been declared a pandemic disease by WHO. The number of infected cases continues unabated and so far, no specific drug approved for targeted therapy. Hence, there is a need for drug discovery from traditional medicine. Tiryaq-e-Wabai is a well-documented formulation in Unani medicine for its wide use as prophylaxis during epidemics of cholera, plague and other earlier epidemic diseases. The objective of the current study is to generate in-silico evidence and evaluate the potency of Tiryaq-e-Wabai against SARS-CoV-2 spike (S) glycoprotein and main protease (3CLpro). The structures of all phytocompounds used in this study were retrieved from PubChem database and some were built using Marvin Sketch. The protein structure of the SARS-CoV-2 S glycoprotein and 3CLpro was retrieved from the PDB ID: 6LZG and 7BQY respectively. AutoDock Vina was used to predict top ranking poses with best scores. The results of the molecular docking showed that phytocompounds of Tiryaq-e-Wabai exhibited good docking power with spike glycoprotein and 3CLpro. Among tested compounds Crocin from Zafran and Aloin A from Sibr showed strong binding to spike glycoprotein and 3CLpro respectively. Molecular dynamics simulation confirmed the stability of the S glycoprotein- Crocin and 3CLpro-Aloin A complexes. The Unani formulation Tiryaq-e-Wabai has great potential to inhibit the SARS-CoV-2, which have to be substantiated with further in-vitro and in-vivo studies. [ABSTRACT FROM AUTHOR]

Hasat-ul Kilya (Nephrolithiasis) is one of the most common chronic conditions and has been known to the mankind since antiquity. The incidence is increasing globally with geographic, racial and gender variation in its occurrence. Medical management of Nephrolithiasis still poses a considerable challenge for modern medical practice. Unani drugs possessing lithotriptic activity are not only cost effective but also have least side effects. Safūf Hajar-al Yahūd has been used since long for the treatment of Hasat-ul Kilya (Nephrolithiasis) but no documentary evidence based on scientific parameters as to its safety and efficacy are available. To validate the safety and efficacy of Safūf Hajar-al Yahūd in the treatment of Hasat-ul Kilya. An open prospective clinical trial was carried out on 107 subjects of renal calculi of 3–7 mm diameter diagnosed by Ultrasonogram-KUB (USG-KUB). Subjects were evaluated by clinical history & examination, laboratory investigations followed by USG-KUB for confirmation. The safety was assessed by reporting of adverse events and by pathological and biochemical investigations. Assessment of efficacy was based on improvement observed in VAS score and expulsion/reduction of stone size as detected by USG-KUB. Substantial reduction (53%) in the size of calculi confirmed by USG-KUB and considerable lowering of VAS score (75%) were observed with the active intervention in majority of the cases The trial has revealed that the Unani pharmacopoeal formulation Safūf Hajar-al Yahūd was well tolerated and has the therapeutic potential in the reduction and expulsion of renal calculi. [ABSTRACT FROM AUTHOR]

Coronavirus disease 2019 (COVID-19) is arguably the biggest health crisis the world has faced in 21st century. It is an infectious disease and declared pandemic by the World Health Organization. It is a pandemic disease of modern time with unique and rapid transmission rate and affected almost all the nations without respecting any border. It's a novel infection which is caused by SARS CoV -2 with Serious Clinical manifestation i.e. Fever, Cough, Cold, Respiratory distress further may result into Death. There is no definite therapeutic drug or vaccine available for COVID-19 so far despite numerous series of experimental and clinical research. Research is in progress on therapeutic efficacy of various agents including antimalarials (Chloroquine and Hydroxychloroquine), antiviral drugs, and convalescent serum of recovered patients. Unani system of medicine is one of the traditional systems of medicine which is being explored for providing preventive, supportive and rehabilitative care to patients. Unani system of medicine has a detailed description of drugs that are utilized in many infectious diseases, including respiratory infections. Immune response is essential to eliminate virus and to preclude disease progression to severe stages. Therefore, strategies to boost immune response are certainly important. Therefore, it is important to summarize the evidence regarding the preventive measures, control options such as immunostimulator and prophylactic treatment in Unani medicine against Covid- 19. This review summarizes various pharmacological actions of Unani formulation Tiryaq e wabai in unani literature and various reported pharmacological activities which can possibly provide prevention, control and reduction of complications of this deadly disease. [ABSTRACT FROM AUTHOR]

Hing (Family- Umbelliferae) or asafoetida is the latex obtained from living rootstocks or taproots of several species of Ferula, e.g. F. alliacea Boiss, F. rubricaulis Boiss, F. assafoetida Linn and F. narthex Boiss found in central Asia. Asafoetida occurs in three forms, viz Tears, Mass and Paste. Hing has shown diverse biological and pharmacological activities. It has been used in Unani Medicine (Tibb-e-Unani) and other Traditional Systems of Medicine from time immemorial and it is described as diuretic, anti-diabetic, emmenagogue etc. The present review highlights the botanical description, traditional uses, pharmacognositcal features, pharmacological properties and pharmacological studies conducted on this Medicinal plant used in Unani system of medicine. [ABSTRACT FROM AUTHOR]

Unani System of medicine is one among the oldest systems of medicine that prevails till date with its efficient drugs derived from animal, plant and mineral resources. Over 2400 years ago the father of medicine, Hippocrates practiced it, however His medicine included a great deal of ancient Egyptian Medicine as well as important components of the ancient Mesopotamian traditions. This system of medicine has a detailed description of drugs that are utilized in many infectious diseases like influenza, pneumonia and other respiratory disorders. Unani scholars have prescribed several single drugs as well as compound formulations for the prevention and treatment of infectious diseases in general. Tiryaq e Arba is one such formulation, which is known to improve host immunity anytime or during the outbreak of epidemics, endemics and pandemics. Through this paper, an attempt has been made to present Unani concept of infectious and epidemic diseases and details of Tiryaq e Arba with a possible approach to manage Covid-19. [ABSTRACT FROM AUTHOR]

In visible light communication (VLC), the data is transmitted by modulating the light emitting diode (LED). The data-rate is throttled by the narrow modulation bandwidth of LEDs, which becomes a barrier for attaining high transmission rates. Non-orthogonal multiple access (NOMA) is a new scheme envisioned to improve the system capacity. In addition to multiple access schemes, optimization techniques are applied to further improve the data rate. In this letter, convex optimization is applied to NOMA-based VLC system for downlink. The proposed optimization system is analyzed in terms of the bit error rate (BER) and the sum-rate. [ABSTRACT FROM AUTHOR]

Background: Evolvulus alsinoidesis a well-known herbal drug possessing various promising medicinal properties described by prominent ancient scholars and also numerous preclinical and clinical researches has been performed, thus at testing it’s ample of pharmacological actions. So, thorough review of classical as well as contemporary literature has been executed on Evolvulus alsinoides to validate the pharmacological actions mentioned. . Methods: For classical review, a comprehensive search of Unani literature is done and for latest research work on evolvulus, articles published in English language using PubMed, MEDLINE, and the Google scholar with search term including Sahnkpushpi, sankhaoli, Evolvulus alsinoides since 1991 to 2019 is done. Results: The search includes contemporary literature, ethnomedicinal sources and 35 research articles from 1992 to 2019 which further ascertains various pharmacological actions being mentioned in Unani literature including anti-inflammatory, anti-diarrheal, anti-helminthic, anti-consultant and nootropic property of herb. Conclusion: The pharmacological action and therapeutic application of Shankhaholi/Shankpushpi which is mentioned in classical Unani literature are in accordance with latest research. Despite of having several researches on Evolvulus alsinoides there are still numerous indications mentioned in classical literature which are yet to be explored. [ABSTRACT FROM AUTHOR]

Khar-e-Khasak-khurd (Tribulus terrestris Linn.) commonly known as Gokharu, is used for a long time for treatment of various diseases. Considerable literature is available in Unani system of medicine regarding the medicinal properties of Khar-e-khasak-khurd (Tribulus terrestris Linn.). Its various parts contain a variety of chemical constituents which are pharmacologically active, such as Harmine, Chlorogenin, Tribuloside, Trigogenin. Whole plant and seeds are used as traditional herbal medicine and having properties such as diuretic, aphrodisiac, immunomodulatory, antidiabetic, absorption enhancing, hypolipidemic, cardiotonic, hepatoprotective, antiurolithic, anti-inflammatory, analgesic, antispasmodic, and antibacterial. In the present review, an attempt has been made to cover the major pharmacological actions as well therapeutic uses of Khar-e-khasak-khurd (Tribulus terrestris Linn.) mentioned in Unani system of medicine. [ABSTRACT FROM AUTHOR]

The non-orthogonal multiple access (NOMA) technique is a strong candidate for 5G cellular networks that enable greater multiuser capacity and user fairness through multiplexing in the power domain. The user data are pulse-shaped using the orthogonal frequency-division multiplexing (OFDM) technique based on the fast Fourier transform (FFT) for conventional NOMA. We propose a discrete wavelet transform-based pulse shaping technique for NOMA. We present a closed-form expression of the bit error rate (BER) for FFT-NOMA as well as wavelet-based NOMA (WNOMA) systems. The theoretical and simulation BER results show that WNOMA outperforms FFT-NOMA in additive white Gaussian noise. [ABSTRACT FROM AUTHOR]

Arthritis is described in Unani system of Medicine under a broad term Waja'al-Mafāsil which covers entire joint disorders like inflammatory, non-inflammatory, infectious, metabolic and other musculoskeletal disorders. According to Unani concept, the pathological changes in the joints are caused mainly by derangement of humoural (Akhlat) temperament and accumulation of Fasid madda (Morbid material) in the joint spaces. The main principles of treatment in Unani system of Medicine include Ilaj bi'l Ghidha (Dieto-therapy), Ilaj bi'l Tadbir (Regimenal therapy) and Ilaj bi'l Dawa (Pharmacotherapy). All the said principles are recommended for the treatment of Waja'al-Mafāsil. The aim of treatment for patient with Waja'al-Mafāsil is to reduce morbidity and disability. In India it affects 15% (180 million) people. Ancient Unani scholars have elaborately described Waja'al-Mafāsil and managed with multidimensional approach, whereas with the present day management of disease mainly with non-steroidal anti-inflammatory drugs (NSAIDs) which have large number of adverse effects. This review article highlight the salient features describing arthritis with reference to Waja'al-Mafāsil for empathizing disease condition as enunciated by Unani scholars to provide a better alternative in terms of cost effective managements and side effects. [ABSTRACT FROM AUTHOR]

To evaluate the effect of Maghz-e-Jamun (Eugenia jambolana) on blood sugar and insulin levels in prediabetic stage (Intermediate hyperglycemic state). It was randomized, single blind, placebo controlled study of 52 prediabetic patients (diagnosed according to ADA classification) randomly allocated in test and control group. Maghz-e-Jamun (Eugenia jambulana) powder 4.5g was filled in 6 capsules, 3 capsules was given orally twice a day for 12 weeks in test group. Whereas, in control group, placebo prepared with starch was given in the same form and dosage as in test group for the same duration. During the protocol therapy, patient in both the groups were asked to follow the prescribed diet as provided by dietician. Patients were also asked to take brisk walk in morning daily for 40 minutes. FBS, BSPP was assessed on baseline, 28th day and 84th day of therapy, while HbA1c, Serum insulin Fasting and HOMA-IR were assessed after 12 weeks. For the assessment of safety of the drug and placebo, complete haemogram, LFT, KFT and Urine R/M was done on baseline, 28th day and 84th day of the study. Significant reduction in FPG from (105.67 ±2.20) to (96.03 ±1.94) were noted after 28th day in prediabetics with p value 0.001**, the FPG further declined to (92.13±1.50) after 84th day of follow up in the test group in which powder of the seeds of Eugenia jambolana were given. BSPP declined from (130.33±3.44) to (118.83± 2.65) after 28 day and become (121.93±3.16) after 84 day with p value 0.012* and 0.071 respectively. Highly significant reduction in value of HbA1c was revealed from (5.82±0.09) to (5.55±0.08) with p value 0.001**. As far as level of serum insulin fasting is concerned, no changes in insulin level was found after 84 day of administration of Maghz-e-Jamun (Eugenia jambolana) in prediabetics. Slight reduction in value of HOMA-IR was found before and after the intervention i.e., (2.85±0.25) from (3.05±0.30). No significant changes are revealed after 28 days as well after 84 days of intervention in safety profiles laboratory investigations which are complete haemogram, LFT, KFT and Urine R/M. Maghz-e-Jamun (Eugenia jambolana) exhibited good glucose control in prediabetic condition. It can also revert the prediabetic condition into normoglycemia and prevent the conversion of prediabetic condition into Type 2 diabetes if supported with dietary intervention and exercise. [ABSTRACT FROM AUTHOR]

Unani System of medicine is one among the oldest systems that prevails till date with its efficient drugs derived from animal, plant and mineral resources. Over 2400 years ago the father of medicine, Hippocrates practiced it, however His medicine included a great deal of ancient Egyptian medicine as well as important components of the ancient Mesopotamian traditions. In Unani system of medicine, arthritis is described under a broad term Waja-ul-Mafasil which encompasses entire joint disorders like inflammatory, non-inflammatory, infectious, metabolic and other musculoskeletal disorders. A large number of drugs, single and compound formulations, have been mentioned in the context of the treatment of Waja-ul-Mafasil. Among them, Majoon Suranjan is one of the most reputed poly pharmaceutical preparations of Unani system of Medicine used in Waja-ul-Mafasil. It is attributed to Indrumakhas of Greece (Andromachos, the elder, court physician to King Nero) who formulated it in consultation with several other philosophers of his time. This Unani compound formulation contains twenty one ingredients, which is used as digestive, purgative, anti inflammatory, stomachic, deobstruent, antiarthritic, nervine tonic. It is also indicated for use in phlegmatic diseases. [ABSTRACT FROM AUTHOR]

Certain radar applications may require maintaining the difference pattern slope and twin beam shape, while main null is scanning in the presence of mutual coupling. It is also desirable in monopulse radar applications to be able to generate acceptable sum and difference patterns using single simplified feed structure. This paper focuses on these problems and provides a solution based on Intelligent z-Plane Boundary Condition-Particle Swarm Optimiser (IzBC-PSO) to compensate for the difference pattern degradation while scanning a small coupled array (N=8). In second case, a simplified feed is proposed that only requires phase flip for 50% of elements to produce sum and difference patterns for the monopulse array, consisting of isotropic elements. [ABSTRACT FROM AUTHOR]

Today the world is witnessing a rise in incidence of diseases and the demand for affordable health care has increased manifold. An effective and robust public health system is the need of the hour to improve the health and wellbeing of people across the globe. Unani Medicine is a holistic system of medicine, which offers indigenous and effective therapies, which are already helping millions of people across the globe in living a healthy life. Unani medicine gained momentum as an effective alternative to conventional medicine due to its systematic approach towards diagnosis and treatment of diseases, effective management of lifestyle disorders and primary focus on prevention of ailments. This system of medicine, which has its origin from Greece, today has a presence in many parts of the globe. Besides India, it is practiced in several countries like Bangladesh, South Africa, Pakistan, Iran, United Arab Emirates and Sri Lanka etc. The Government of India facilitated the growth and development of Unani medicine by recognizing its utility and scope and integrated it into healthcare delivery system. With its wide network of quality educational institutions, comprehensive healthcare facilities, state of the art research institutions and quality drug manufacturing industries and on account of its utilization by a large number of people for their healthcare needs, India has emerged as the global leader in Unani medicine. Concerted efforts are being made to carry out high quality, evidence based research and to make the system more accessible and affordable. Unani medicine can contribute a wealth of knowledge and experience for the benefit of human kind and has the potential to be one of the major contributors in health care delivery in other parts of the globe. [ABSTRACT FROM AUTHOR]

This study concerns wide angular sector (higher order) null synthesis in planar irregular sparse antenna arrays when aperture distributed sub-arrays are used to reduce the computational load. A hybrid optimisation tool has been used to find array element excitations to achieve as low as possible sector nulls for the desired sector width. Performance comparisons have been made for three sub-array configurations based on the obtained numerical results. Various interference jamming scenarios have been considered including single and dual sectors for single-dimensional (θ) (1D) and two-dimensional (θ, ϕ) (2D) nulls. The proposed optimisation scheme has shown to be successful for the synthesis of 1D and 2D sector nulls with depths as low as -100 dB for the given configuration with reduced computational time when compared with the full array. The comparison of achieved null depths for different sub-array sizes and convergence time has also been presented and discussed. [ABSTRACT FROM AUTHOR]

Naturally, existing lignocelluloses fibers showed outstanding potential in paper industry and other conventional applications. On the other hand, lignocellulose fibers are suitable candidate for high-tech applications under the scope of abundance, flexibility, light-weight and environment friendliness. In this study, paper sheets were prepared from lignocelluloses fibers extracted from self-growing plant, typha angustifolia. Lignocelluloses paper sheets were characterized for scanning electron microscopy (SEM), universal testing machine (UTM) and vector network analyzer (VNA). Flexible paper sheets displayed a tensile strength of 9.1 MPa and further used as a substrate in patch antenna to observe dielectric characteristics. The patch antenna is designed at 5.1 GHz which showed return loss less than −10 dB and dielectric constant 3.71. The use of lignocelluloses paper sheet as a substrate in patch antenna will provide the opportunity of miniaturization of size and weight in comparison of a jean substrate based antenna. [ABSTRACT FROM AUTHOR]

Aim of the Study: The aim of the following study is to evaluate the efficacy and tolerability of a compound Unani formulation in hyperlipidemia on clinical and biochemical parameters. Materials and Methods: A total of 90 patients with total cholesterol level of 220 mg/dl and above were included. In Group 'A' thirty patients with total cholesterol 243.5 ± 5.294 mg/dl received Unani formulation safoof-e-muhazzil (SM) in its classical powder form 5 g twice daily orally, in Group 'B' thirty patients with total cholesterol 234 ± 3.822 mg/dl received the SM but in compressed tablet form in the same dosage and in Group 'C' 30 patients with total cholesterol 242.7 ± 5.563 mg/dl received atorvastatin 10 mg as a standard control. Follow-up was carried out on second, fourth and 6th week and patients were evaluated on clinical as well as biochemical parameters. Results: Group A before treatment had mean total cholesterol of 243.5 ± 5.294 mg/dl which decreased significantly after treatment to 225.6 ± 5.953 mg/dl (P < 0.001) with a percentage change of 7.35%. Group B had mean total cholesterol of 234 ± 3.822 mg/dl which was significantly reduced to 212.67 ± 3.94 mg/dl (P < 0.001) post-treatment with a percentage change of 9.11%. Control Group C having mean total cholesterol of 242.7 ± 5.563 mg/dl before treatment was significantly decreased to 178.73 ± 4.669 mg/dl (P < 0.001) post-treatment with a percentage change of 26.3%. Group A had significant relief 20.72% (P < 0.001) in fatigue, 16.09% (P > 0.5) relief in palpitation and 26.17% (P < 0.001) relief in dyspnea post-treatment. Group B fatigue decreased significantly by 18.14% (P < 0.01), palpitation by 22.91% (P < 0.01) and dyspnea by 20.46% (P < 0.01). In Group C a non-significant increase of 2.2% was observed in fatigue post-treatment, palpitation decreased by 10.22% non-significantly and dyspnea decreased significantly by 17.64% (P < 0.001). Results indicate that the test drug safely and effectively ameliorates the clinical condition of patients with hyperlipidemia while decreasing cholesterol level as well. [ABSTRACT FROM AUTHOR]

Sparse antenna arrays with irregularly spaced elements are increasingly being used in large array applications such as radio astronomy and radar. These antenna arrays may consist of hundreds of elements and therefore optimisation of these arrays becomes computationally expensive. This study proposes a novel solution to the problem of null synthesis in such arrays, where nulls are formed in prescribed locations for two-dimensional irregular sparse antenna arrays. The technique is based on a subarray and hybrid synthesis solution, where each subarray spans the entire antenna aperture. Single and multiple null formations with array gain maximisation are considered. The technique's effectiveness is demonstrated using evolutionary optimisation algorithms; however, the basic technique can be used with other optimisation methods. The simulation results presented compare the null synthesis performance with and without subarraying and it has shown that the use of subarray results in improved convergence compared with a direct full array synthesis. Furthermore the technique is appropriate for ready application to parallel computer architectures. [ABSTRACT FROM AUTHOR]

The study aimed to evaluate the effect of cupping therapy at a clinical setting for knee osteoarthritis. A randomized, controlled clinical trial was conducted. Cupping was performed on 0-6th day; 9-11th day and 14th day, i.e., 11 sittings follow-up to determine longer term carryover of treatment effects utilizing both objective and subjective assessment. The assessment was performed before and after treatment spreading over a period of 15 days. The results of this study shows significant and better results in the overall management of knee osteoarthritis, particularly in relieving pain, edema, stiffness and disability. The efficacy of treatment with cupping therapy in relieving signs and symptoms of knee osteoarthritis is comparable to that of acetaminophen 650 mg thrice a day orally, in terms of analgesia, anti-inflammatory and resolution of edema with minimal and temporary side-effects like echymosis and blister formation while as control drug has greater side-effects particularly on upper gastrointestinal tract. It is recommended that further studies are conducted with a larger study samples and of longer duration. [ABSTRACT FROM AUTHOR]

The aim of this study is to evaluate the efficacy of a Unani formulation in hypertension. A total of 90 patients with total cholesterol level of more than 220 mg/dl with associated conditions were included in this study. A total of 30 patients having a mean systolic blood pressure (BP) of 133.86 mmHg comprising Group A received Unani formulation Safoof-e-Muhazzil (SM) in its classical powder form in the dose of 5 g twice a day orally. Group B comprising of 30 patients with a mean systolic BP of 133.13 mmHg received same drug, but in compressed tablet form in the same dosage, whereas, 30 patients comprising Group C with a mean systolic BP of 129.45 mmHg, received Atorvastatin 10 mg as a standard control. Patients were evaluated on each follow-up at 2nd, 4th and 6th week. The mean systolic BP in Group A and B before treatment was 133.86 ± 3.028 mmHg and 133.13 ± 2.852 mmHg, which significantly decreased to 119.33 ± 1.922 mmHg (P < 0.001) and 119 ± 1.760 mmHg (P < 0.001) respectively. In the control Group C before treatment BP was 129.45 ± 2.499 mmHg and after treatment it significantly decreased to 124.34 ± 1.794 mmHg (P < 0.01). The percentage change after treatment was 10.85%, 10.61% and 3.94% respectively in each group. Mean diastolic BP in Group A and B before treatment was 85.06 ± 2.11 mmHg and 84.56 ± 1.5 mmHg, which significantly decreased to 79.06 ± 1.56 mmHg (P < 0.001) and 79.96 ± 1.15 mmHg (P < 0.001) respectively, BP before treatment in Group C was 83.23 ± 1.588 mmHg, which was decreased to 124.34 ± 1.794 mmHg (P < 0.01). The study results indicate that the test drug was quite effective in reducing both systolic as well as diastolic BP. [ABSTRACT FROM AUTHOR]